ADVERTISEMENT

Johnson & Johnson India Sales Declined 3% In 2017-18

Johnson & Johnson reported sales of Rs 5,828 crore in India for 2017-18 Its after-tax profit rose 18% to $98 million on other income J&J medical device sales have been hit after Centre's move to cap prices

Johnson & Johnson is mired in a controversy surrounding the safety of its baby talcum powder
Johnson & Johnson is mired in a controversy surrounding the safety of its baby talcum powder
Johnson & Johnson's sales in India dipped 3 per cent in the year to March 2018, a regulatory filing showed on Thursday, as the US drug maker grappled with the country's stringent medical device pricing policies.
Register for Free
to continue reading
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit